Back
PTC Therapeutics, Inc. Stock Predictions
$10K Investment in Nvidia Could've Made $2.5M
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi
Sell
37
PTCT
PTC Therapeutics, Inc.
Last Price:
$74.65
Seasonality Move:
-7.05%
7 Day Trial
ALL ACCESS PASS
$
7
When an AI Platform Gets Pulled by Too Much Demand
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radiPTC Therapeutics, Inc. Stock Forecast
-
Over the next 52 weeks, PTC Therapeutics, Inc. has on average historically risen by 26.2% based on the past 12 years of stock performance.
-
PTC Therapeutics, Inc. has risen higher in 8 of those 12 years over the subsequent 52-week period, corresponding to a historical accuracy of 66.67%
-
Is PTC Therapeutics, Inc. Stock Undervalued?The current PTC Therapeutics, Inc. [PTCT] share price is $74.68. The Score for PTCT is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
-
PTCT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
Will PTC Therapeutics, Inc. Stock Go Up Next Year?
-
Over the next 52 weeks, PTC Therapeutics, Inc. has on average historically risen by 26.2% based on the past 12 years of stock performance.
PTC Therapeutics, Inc. Stock Rating
Sell
37
PTC Therapeutics, Inc. (PTCT)
is a Sell
Is PTC Therapeutics, Inc. overpriced?
-
PTC Therapeutics, Inc. has risen higher in 8 of those 12 years over the subsequent 52-week period, corresponding to a historical accuracy of 66.67%
PTC Therapeutics, Inc. Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
ptcbio.com
52-Week Data
52-Week High:
87.50
52-Week Low:
35.95
Prediction Charts
Market Cap:
6B
Price in USD:
74.68
Volume:
1M
Beta:
0.83
Technical Analysis
SMA50:
76.65
SMA100:
72.05
SMA200:
60.71
52-Wk Change:
49.99%
Stock Predictions
-
Is PTC Therapeutics, Inc. stock public?Yes, PTC Therapeutics, Inc. is a publicly traded company.
-
What is the PTC Therapeutics, Inc. stock quote today?The PTC Therapeutics, Inc. stock price is 74.68 USD today.
-
How to buy PTC Therapeutics, Inc. stock online?You can buy PTC Therapeutics, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Jan-20 | 71.19 | 73.07 | 73.09 | 69.81 |
| Jan-21 | 73.19 | 75.56 | 76.40 | 72.56 |
| Jan-22 | 75.43 | 76.17 | 77.35 | 74.29 |
| Jan-23 | 75.44 | 75.25 | 77.55 | 74.05 |
| Jan-26 | 74.45 | 76.23 | 77.07 | 73.77 |
| Jan-27 | 76.06 | 75.49 | 77.09 | 74.90 |
| Jan-28 | 76.87 | 75.60 | 78.38 | 75.31 |
| Jan-29 | 76.51 | 76.43 | 78.16 | 75.61 |
| Jan-30 | 76.46 | 75.53 | 77.59 | 74.68 |
| Feb-2 | 75.14 | 74.88 | 76.42 | 73.34 |
| Feb-3 | 75.49 | 74.83 | 76.99 | 74.57 |
| Feb-4 | 74.93 | 73.91 | 75.78 | 72.99 |
| Feb-5 | 73.79 | 72.36 | 75.64 | 71.35 |
| Feb-6 | 73.77 | 74.68 | 75.00 | 72.64 |
PTC Therapeutics, Inc. Earnings
PTC Therapeutics, Inc. Earnings Report: Per Share PTC Therapeutics, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.
PTC Therapeutics, Inc. Forecast Revenue Growth
PTC Therapeutics, Inc. Stock Analysis: Historical quarterly revenues per share for PTC Therapeutics, Inc. and historical quarterly revenue growth:
-
Analysts estimate an earnings decrease this quarter of $0.91 per share, a decrease next quarter of $0.00 per share, a decrease this year of $10.51 per share, and an increase next year of $2.45 per share.
* PTC Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.